Two of Taconic Biosciences's newest products are highlighted in a recent article published in Outsourcing-Pharma. The first, TruBIOME™
, is a comprehensive solution to increase reproducibility in mouse models through custom microbial associations
. The second is the launch of Taconic's new commercial diet-induced NASH mouse model
, which will enable researchers to obtain a model faster for preclinical studies:
"As summer heated up, the pharmaceutical industry saw major developments in preclinical models from new software to 3D-printed tissue, all in the name of drug development.
June 2019 saw the French software firm, Dassault Systémes acquire Medidata for $5.8bn (€5.24m) in an all-cash transaction to combine modeling and simulation with data science. With the acquisition, Medidata became a wholly-owned subsidiary of Dassault Systems."
Read the complete article at: outsourcing-pharma.com